Impaired endothelial function in patients with nephrotic range proteinuria

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Vascular Physiology

Background:

• Proteinuria is a marker for kidney disease and is linked to increased cardiovascular morbidity and mortality.
• Endothelial nitric oxide (NO) release is a key defense mechanism against vascular damage.

Purpose of the Study:

• To investigate the hypothesis that proteinuria is associated with impaired nitric oxide-dependent vasodilation.
• To assess endothelial function in patients with nephrotic range proteinuria and active glomerulonephritis.

Main Methods:

• Venous occlusion plethysmography was used to measure forearm vascular resistance (FVR).
• L-NMMA was infused to inhibit basal nitric oxide production.
• Serotonin (endothelium-dependent vasodilator) and nitroprusside (endothelium-independent vasodilator) were infused intra-arterially.

Main Results:

• Nitric oxide inhibition by L-NMMA similarly reduced FVR in nephrotic patients, non-nephrotic patients, and healthy controls.
• Serotonin-induced vasodilation was significantly blunted in nephrotic subjects compared to non-nephrotic patients and controls.
• Nitroprusside-induced vasodilation was comparable across all groups, indicating preserved smooth muscle function.

Conclusions:

• Proteinuria, particularly nephrotic range, is associated with impaired nitric oxide-dependent vasodilation.
• This defect may contribute to the increased cardiovascular risk observed in patients with proteinuria.
• Findings suggest a potential deficit in nitric oxide production or bioavailability in proteinuric kidney disease.